Table 2.
MIC (μg/mL) of peptide Chain201D tested against clinical isolates of bacteria and yeast (1–5) as determined by the microdilution method.
| Bacterial clinical isolates | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| E. coli | 16 | 1 | 1 | 1 | 1 |
| K. pneumonia | 2 | 2 | 4 | 4 | 2 |
| P. aeruginosa | 4 | 4 | 4 | 2 | 2 |
| E. cloacae | 1 | 2 | 2 | 2 | 1 |
| S. aureus | 1 | 1 | 1 | 1 | 1 |
| S. pneumonia | 8 | 4 | 2 | 4 | 4 |
| A. baumannii | 4 | 4 | 4 | 4 | 4 |
| Yeast clinical isolates | 1 | 2 | 3 | 4 | 5 |
| C. albicans | 16 | 8 | 8 | 16 | 8 |
| C. glabrata | 8 | 8 | 8 | 64 | |
| C. parapsilosis | 8 | 8 | 8 | 8 |